GLDH3
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PRODUCTOSROCHE, S.A. DE C.V.·Registered June 24, 2022PRUEBAINVITROPARALADETERMINACIÓNCUANTITATIVADE GLUTAMATO DESHIDROGENASA (GLDH) EN SUERO YPLASMAHUMANOSENLOSSISTEMASROCHE. AGENTEDEDIAGNÓSTICOPARAUSOINVITRO. PARAUSOEXCLUSIVOEN LABORATORIOS CLÍNICOS O DE GABINETES.
INVITRO TEST FOR THE QUANTITATIVE DETERMINATION OF GLUTAMATE DEHYDROGENASE (GLDH) IN HUMAN SERUM AND PLASMA IN ROCHE SYSTEMS. DIAGNOSTIC AGENTFOR use. FOR USE ONLY IN CLINICAL LABORATORIES OR CABINETS.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LADETERMINACIÓN DEGLUTAMATO DESHIDROGENASA
- Trade Name (English)
- REAGENT FOR THE DETERMINATION OF GLUTAMATE DEHYDROGENASE
- Analysis ID
- 530R2022 SSA
- Registration Date
- June 24, 2022
- Name (Spanish)
- PRODUCTOSROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOSROCHE, S.A. DE C.V.
Access comprehensive regulatory information for GLDH3 (GLDH3) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 530R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on June 24, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.